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The patient is a 71 year old woman with a history of rheumatic fever complicated 
by mitral stenosis and atrial fibrillation who had previously undergone mitral valve 
repair and radio frequency ablation in 2006 followed by a mitral valve 
replacement (MVR), tricuspid valve repair and MAZE procedure in 2008.  She 
subsequently underwent a TAVR in 2016 due to symptomatic severe aortic 
stenosis.  In the ensuing years, she developed progressive shortness of breath 
and severe dyspnea on exertion, requiring home oxygen therapy.  An 
echocardiogram demonstrated severe prosthetic mitral stenosis along with 
severe pulmonary hypertension with a PA systolic pressure of 115 mmHg. 
Given her high risk for surgery, the decision was made to treat her with a ViV 
TMVR.  After induction of general anesthesia (GA) and initiation of treatment with 
nitric oxide (NO) a trans-septal approach was initially attempted.  Through 3D 
TEE imaging and guidance, a trans-septal approach was deemed to be both 
high-risk and technically challenging due to the previous trans-septal approach to 
her MVR along with significant intra-atrial septal wall calcification.  The trans-
apical approach to her MVR was subsequently pursued.  Using 3D TEE 
guidance, a balloon-expandable bioprosthetic trans-catheter valve was 
positioned and successfully deployed. Post-procedural transvalvular gradients 
were 3mmHg along with trivial paravalvular regurgitation.  Post-procedure, her 
PA systolic pressures had declined to 55mmHg.  She was taken to the ICU 
intubated, the NO was weaned and she was extubated.  She was discharged to 
home on POD #5.
TEE guidance with 3D imaging was 
invaluable in this case.  The use of TEE 
guidance in the trans-septal attempt 
resulted in the safest outcome for the 
patient, as it was determined that the 
septum could not be crossed in a safe 
location that would result in a successful 
deployment of the valve due to alteration of 
the septal anatomy by her previous surgical 
procedures.  TEE guidance in the trans-
apical attempt resulted in successful 
positioning and deployment of the valve. 
The use of TEE, and in particular 3D TEE, by skilled 
echocardiographers is essential to the success of 
TMR.
Trans-catheter mitral valve replacement 
(TMVR) remains in it’s infancy when compared 
to trans-catheter aortic valve replacement 
(TAVR).  At present, TMVR is most commonly 
performed in patients with degenerative native 
valve disease with annular rigidity due to mitral 
annular calcification (MAC) or patients with 
bioprosthetic valve degeneration (Valve-in-
Valve (ViV) replacement).1  Real-time, 3D TEE 
guidance is typically used in these cases.2  We 
present a case of a challenging ViV TMVR, in 
which real-time 3D TEE was utilized. 
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Figure 2 Wire through surgical mitral valve
Figure 1 Trans-septal attempt
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